NYSE, KG - King Pharmaceuticals Inc.
King Pharmaceuticals, Inc. was incorporated in the State of Tennessee in 1993.
Our wholly owned subsidiaries are Monarch Pharmaceuticals, Inc.; King
Pharmaceuticals Research and Development, Inc.; Meridian Medical Technologies,
Inc.; Parkedale Pharmaceuticals, Inc.; King Pharmaceuticals Canada Inc.; and
Monarch Pharmaceuticals Ireland Limited.
Our principal executive offices are located at 501 Fifth Street, Bristol,
Tennessee 37620. Our telephone number is (423) 989-8000 and our facsimile number
is (423) 274-8677. Our website is www.kingpharm.com where you may view our
Corporate Code of Conduct and Ethics (?Code?). To the extent permitted by
U.S. ...
Read SEC Filing on NASDAQ.com »